Risk of Unexpected Adverse Effects Resulting from the Use of a Skin Test with Recombinant Tuberculosis Allergen in Children

Risk of Unexpected Adverse Effects Resulting from the Use of a Skin Test with Recombinant Tuberculosis Allergen in Children

This report reviews clinical cases, and their possible causes of unexpected local and systemic adverse effects associated with a novel skin test using recombinant tuberculosis allergen (RTA, Diaskintest) in 2—11 years old children. This preparation consists of a M. tuberculosis ESAT6/CFP10 fusion pr...

Full description

Bibliographic Details
Main Authors:	V. N. Kryvohizh, A. M. Korolyuk
Format:	Article
Language:	Russian
Published:	LLC "Diagnostics and Vaccines" 2016-04-01
Series:	Detskie Infekcii (Moskva)
Subjects:	tuberculosis mycobacterium tuberculosis tuberculin mantoux test recombinant tuberculosis allergen (rta) «diaskintest®» esat6 cfp10 delayed type hypersensitivity (dth) anaphylaxis anaphylactoid reaction
Online Access:	https://detinf.elpub.ru/jour/article/view/203

Similar Items

EFFICIENCY OF USING TUBERCULOUS RECOMBINANT ALLERGEN FOR SCREENING FOR TUBERCULOUS INFECTION IN CHILDREN AND ADOLESCENTS IN STAVROPOL KRAY
by: O. D. Baronova, et al.
Published: (2016-08-01)

Recombinant in vitro test T-SPOT.TB as a screening method for early diagnosis of tuberculosis infection
by: E. P. Eremenko, et al.
Published: (2020-05-01)

Recombinant tuberculosis allergen (Diaskintest®) in tuberculosis diagnostic in Russia (meta-analysis)
by: Anna Starshinova, et al.
Published: (2020-01-01)

Efficiency of screening for tuberculosis infection in children and adolescents in Moscow in 2019 based on the new procedure for using the intradermal test with tuberculosis recombinant allergen (ESAT-6/CFP-10)
by: L. V. Slogotskaya, et al.
Published: (2021-02-01)

EXPERIENCE OF USING TUBERCULOUS RECOMBINANT ALLERGEN FOR DIAGNOSTICS OF TUBERCULOSIS IN HIV PATIENTS
by: N. V. Eysmont
Published: (2015-10-01)

Evaluation of specific antibodies against Mycobacterium tuberculosis recombinant antigens for detection of recent infection
by: Majid Tebianian, et al.
Published: (2016-01-01)

Induration or erythema diameter not less than 5 mm as results of recombinant fusion protein ESAT6-CFP10 skin test for detecting M. tuberculosis infection
by: Hui Zhang, et al.
Published: (2020-09-01)

Diagnostic value of immunological skin tests in children with tuberculosis
by: A. G. Smetanin, et al.
Published: (2015-01-01)

A comparison of intradermal test with recombinant tuberculosis allergen (diaskintest) with other immunologic tests in the diagnosis of tuberculosis infection
by: Anna Starshinova, et al.
Published: (2018-01-01)

TB SKIN TEST RESPONSE IN CHILDREN WITH HIV INFECTION
by: N. I. Klevno
Published: (2014-07-01)

ON VACCINATION OF ADOLESCENTS AGAINST TUBERCULOSIS
by: L. A. Zazimko, et al.
Published: (2014-01-01)

CHANGES IN SENSITIVITY TO SKIN TEST WITH RECOMBINANT TUBERCULOUS ALLERGEN IN CHILDREN WITH LATENT TUBERCULOSIS INFECTION
by: E. P. Shilova, et al.
Published: (2015-09-01)

Long-term results of using the skin test with tuberculosis recombinant allergen for tuberculosis detection in Stavropol Region
by: O. D. Baronova, et al.
Published: (2019-05-01)

Features Immunodiagnostic Local Forms of Tuberculosis in Children
by: E. A. Borodulina, et al.
Published: (2015-08-01)

Two-Hit in vitro T-Cell Stimulation Detects Mycobacterium tuberculosis Infection in QuantiFERON Negative Tuberculosis Patients and Healthy Contacts From Ghana
by: Ernest Adankwah, et al.
Published: (2019-07-01)

Macrophage Immune Response Suppression by Recombinant Mycobacterium tuberculosis Antigens, the ESAT-6, CFP-10, and ESAT-6/CFP-10 Fusion Proteins
by: Atefeh Seghatoleslam, et al.
Published: (2016-07-01)

Efficiency of screening for tuberculous infection among children in Tatarstan Republic
by: R. Kh. Fatykhova, et al.
Published: (2016-06-01)

Elimination of ESAT-6 and CFP-10 from a candidate vaccine against bovine tuberculosis impaired its protection efficacy in the BALBc mouse model
by: Elizabeth A García, et al.
Published: (2020-01-01)

Screening of health-care workers for latent tuberculosis infection in a Tertiary Care Hospital
by: Anand Bimari Janagond, et al.
Published: (2017-01-01)

Cloning, expression and purification of Mycobacterium tuberculosis ESAT-6 and CFP-10 antigens
by: Shima Mahmoudi, et al.
Published: (2013-12-01)

Comparative evaluation of immunological tests for at-risk children in Tomsk Region
by: N. N. Kabanets, et al.
Published: (2017-01-01)

TUBERCULIN DIAGNOSTICS: TO BE OR NOT TO BE?
by: N. M. Koretskaya
Published: (2013-09-01)

Mycobacterium tuberculosis epitope-specific interferon-g production in healthy Brazilians reactive and non-reactive to tuberculin skin test
by: Bosco Christiano Maciel da Silva, et al.
Published: (2014-12-01)

Comparative description of immunological tests for tuberculous infection detection. Mass screening opportunities.
by: L. V. Slogotskaya, et al.
Published: (2016-05-01)

Use of enzyme linked immunospot assay (ELISpot) for monitoring treatment response of pulmonary tuberculosis patients
by: Ramadan M. Nafae, et al.
Published: (2013-07-01)

EXPERIENCE OF USING RECOMBINANT ALLERGEN OF MYCOBACTERIUM TUBERCULOSIS FOR DIAGNOSTICS OF TUBERCULOUS INFECTION
by: T. A. Parfenova
Published: (2016-09-01)

Manifestations of tuberculous infection in children with a positive result of the test with tuberculosis recombinant allergen
by: E. P. Shilova, et al.
Published: (2019-09-01)

Comparative Evaluation of Allergodiagnostic of Tuberculosis in Children
by: I. V. Mikheeva, et al.
Published: (2016-06-01)

Teste tuberculínico. Como optimizar? Tuberculin skin test. How to optimise?
by: Raquel Duarte
Published: (2009-03-01)

Níveis de citocinas e quimiocinas em pacientes com tuberculose determinados pelo ensaio citométrico de esferas ordenadas
by: Almeida, Caroline de Souza
Published: (2016)

Reasons for late diagnostics of tuberculosis in adolescents
by: E. S. Ovsyankina, et al.
Published: (2019-03-01)

Immunodiagnostics of tuberculosis infection <i>in vitro</i> in solving the issue of prescribing preventive chemotherapy
by: E. P. Eremenko, et al.
Published: (2020-09-01)

Purification and biological analysis of specific antigens (ESAT6/CFP10) from Mycobacterium tuberculosis
by: Naheed Mojgani, et al.
Published: (2020-12-01)

HIV INFECTION AS A RISK FACTOR OF TUBERCULOSIS IN CHILDREN
by: E. P. Eremenko, et al.
Published: (2017-01-01)

Advances and Prospects in the Prevention, Diagnosis, and Treatment of Tuberculosis in Children
by: V. A. Aksenova
Published: (2016-11-01)

CRITERIA OF TUBERCULOSIS TREATMENT EFFICIENCY IN CHILDREN UNDER CURRENT CONDITIONS
by: N. A. Barmina, et al.
Published: (2017-11-01)

Comparison of efficacy of Diaskintest<sup>®</sup>, a skin test with a recombinant tuberculosis allergen, used for 10 years and Mantoux tuberculin sensitivity test used for 110 years
by: L. V. Slogotskaya, et al.
Published: (2018-02-01)

Evaluation of three different administration routes (IM, SC and IN) on humoral immune responses against Mycobacterium Tuberculosis ESAT-6/CFP-10 fusion protein
by: Mojdeh Namvarpour, et al.
Published: (2017-10-01)

The diagnosis of latent tuberculosis infection in children in XXI century. Is tuberculin skin test still up to date?
by: Teresa Bielecka, et al.
Published: (2015-10-01)

Evaluation of Serum Specific Antibody against Recombinant ESAT-6 Antigen in Patients with Tuberculosis and Comparing to Normal Controls
by: Homeira Izadi, et al.
Published: (2017-02-01)